Do systemic inflammation and hyperglycemia impair blood-brain barrier integrity?

Systemic inflammation and hyperglycemia have convergent effects on the blood–brain barrier (BBB), particularly at the endothelial tight junctions that regulate exchange between blood and the central nervous system. The overall claim is supported with moderate confidence.

Clinical and experimental evidence

• In severe human inflammatory illness, including fatal sepsis, reduced or absent endothelial occludin has correlated with higher C-reactive protein and greater organ failure. Clinical inflammatory states are also associated with increased BBB solute permeability, reflected by measures such as an elevated CSF/serum albumin ratio and postmortem fibrinogen.
• In human brain microvascular endothelial-cell models, TNF-α and IL-6 increase permeability while reducing occludin, claudin-5, and ZO-1—key proteins maintaining endothelial barrier integrity.
• High-glucose exposure similarly increases permeability and inflammatory signaling in cultured brain endothelial cells. Diabetic animal models show disrupted or reduced claudin-5 and occludin alongside BBB dysfunction.
• Human type 2 diabetes studies generally, though not uniformly, find greater BBB permeability by albumin-ratio and imaging-based measures. These findings are consistent with an effect of hyperglycemia but cannot separate it fully from diabetes duration and vascular comorbidities.

Mechanistic interpretation

• Tight-junction loss provides a biologically direct route from inflammation or elevated glucose to a “leakier” BBB. Hyperglycemia may promote this through oxidative stress and cytokine- and MMP-9-related pathways, while inflammatory cytokines directly downregulate junctional proteins.
• Greater BBB permeability plausibly permits greater passage of circulating immune-related substances; however, direct demonstration of entry of specific circulating cytokines into the living human CNS remains limited.

Bottom line

• Both systemic inflammation and hyperglycemia can impair BBB endothelial tight junctions and increase barrier permeability. This is most directly established in cellular and animal work and supported by severe-illness and diabetes observations in humans.